IGM Biosciences Inc (IGMS)

Finanzdaten der IGM Biosciences Inc-Aktie (IGMS)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	27.90% 0.651	0.509	0.448	0.522	0.372
Operating Expenses	2.23% 65.77	67.27	68.66	63.90	56.64
Benefits Costs and Expenses	1.85% 61.10	62.26	64.76	59.74	52.95
Costs And Expenses	2.23% 65.77	67.27	68.66	63.90	56.64
Operating Income/Loss	2.46% -65.12	-66.76	-68.21	-63.37	-56.26
Nonoperating Income/Loss	6.88% 4.666	5.011	3.894	4.152	3.688
Income/Loss From Continuing Operations Before Tax	2.10% -60.45	-61.75	-64.31	-59.22	-52.58
Income Tax Expense/Benefit	0.83% 0.242	0.24	0.109	0.087	-
Income/Loss From Continuing Operations After Tax	2.09% -60.70	-61.99	-64.42	-59.31	-52.58
Net Income/Loss	2.09% -60.70	-61.99	-64.42	-59.31	-52.58
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	95.75% 2.5332	59.58	45.12	44.47	0.9091
Diluted Average Shares	95.75% 2.5332	59.58	45.12	44.47	0.9091
Basic Earnings Per Share	5.77% -0.98	-1.04	-1.43	-1.33	-1.17
Diluted Earnings Per Share	5.77% -0.98	-1.04	-1.43	-1.33	-1.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-